Literature DB >> 22135314

GPR48 increases mineralocorticoid receptor gene expression.

Jiqiu Wang1, Xiaoying Li, Yingying Ke, Yan Lu, Feng Wang, Nengguang Fan, Haiyan Sun, Huijie Zhang, Ruixin Liu, Jun Yang, Lei Ye, Mingyao Liu, Guang Ning.   

Abstract

Aldosterone and the mineralocorticoid receptor (MR) are critical to the maintenance of electrolyte and BP homeostasis. Mutations in the MR cause aldosterone resistance known as pseudohypoaldosteronism type 1 (PHA1); however, some cases consistent with PHA1 do not exhibit known gene mutations, suggesting the possibility of alternative genetic variants. We observed that G protein-coupled receptor 48 (Gpr48/Lgr4) hypomorphic mutant (Gpr48(m/m)) mice had hyperkalemia and increased water loss and salt excretion despite elevated plasma aldosterone levels, suggesting aldosterone resistance. When we challenged the mice with a low-sodium diet, these features became more obvious; the mice also developed hyponatremia and increased renin expression and activity, resembling a mild state of PHA1. There was marked renal downregulation of MR and its downstream targets (e.g., the α-subunit of the amiloride-sensitive epithelial sodium channel), which could provide a mechanism for the aldosterone resistance. We identified a noncanonical cAMP-responsive element located in the MR promoter and demonstrated that GPR48 upregulates MR expression via the cAMP/protein kinase A pathway in vitro. Taken together, our data demonstrate that GPR48 enhances aldosterone responsiveness by activating MR expression, suggesting that GPR48 contributes to homeostasis of electrolytes and BP and may be a candidate gene for PHA1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22135314      PMCID: PMC3269176          DOI: 10.1681/ASN.2011040351

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  50 in total

1.  Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus.

Authors:  M Ito; Y Oiso; T Murase; K Kondo; H Saito; T Chinzei; M Racchi; M O Lively
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

2.  Regulation of mineralocorticoid receptor expression during neuronal differentiation of murine embryonic stem cells.

Authors:  Mathilde Munier; Geri Meduri; Say Viengchareun; Philippe Leclerc; Damien Le Menuet; Marc Lombès
Journal:  Endocrinology       Date:  2010-03-05       Impact factor: 4.736

3.  Lgr4 is required for Paneth cell differentiation and maintenance of intestinal stem cells ex vivo.

Authors:  Roxana C Mustata; Tom Van Loy; Anne Lefort; Frédérick Libert; Sandra Strollo; Gilbert Vassart; Marie-Isabelle Garcia
Journal:  EMBO Rep       Date:  2011-04-21       Impact factor: 8.807

4.  Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.

Authors:  M Viemann; M Peter; J P López-Siguero; G Simic-Schleicher; W G Sippell
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

5.  Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults.

Authors:  David S Geller; Junhui Zhang; Maria-Christina Zennaro; Alberto Vallo-Boado; Juan Rodriguez-Soriano; Laszlo Furu; Robert Haws; Daniel Metzger; Barbara Botelho; Lefkothea Karaviti; Andrea M Haqq; Howard Corey; Sandra Janssens; Pierre Corvol; Richard P Lifton
Journal:  J Am Soc Nephrol       Date:  2006-04-12       Impact factor: 10.121

6.  Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the beta-subunit of the amiloride-sensitive epithelial sodium channel.

Authors:  S Pradervand; P M Barker; Q Wang; S A Ernst; F Beermann; B R Grubb; M Burnier; A Schmidt; R J Bindels; J T Gatzy; B C Rossier; E Hummler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

7.  Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism.

Authors:  Paola Sartorato; Anne-Laure Lapeyraque; Decio Armanini; Ursula Kuhnle; Yasmina Khaldi; Rémi Salomon; Véronique Abadie; Eliana Di Battista; Arturo Naselli; Alain Racine; Maurizio Bosio; Massimiliano Caprio; Véronique Poulet-Young; Jean-Pierre Chabrolle; Patrick Niaudet; Christiane De Gennes; Marie-Hélène Lecornec; Elodie Poisson; Anna Maria Fusco; Paola Loli; Marc Lombès; Maria-Christina Zennaro
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

8.  Silencing of the mineralocorticoid receptor by ribonucleic acid interference in transgenic rats disrupts endocrine homeostasis.

Authors:  Hee-Young Lim; Jens van den Brandt; Martin Fassnacht; Bruno Allolio; Marco J Herold; Holger M Reichardt
Journal:  Mol Endocrinol       Date:  2008-03-12

9.  Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor.

Authors:  A A van Vliet; A J Donker; J J Nauta; F W Verheugt
Journal:  Am J Cardiol       Date:  1993-01-21       Impact factor: 2.778

Review 10.  The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology.

Authors:  Say Viengchareun; Damien Le Menuet; Laetitia Martinerie; Mathilde Munier; Laurent Pascual-Le Tallec; Marc Lombès
Journal:  Nucl Recept Signal       Date:  2007-11-30
View more
  22 in total

Review 1.  Soluble adenylyl cyclase in health and disease.

Authors:  Andreas Schmid; Dimirela Meili; Matthias Salathe
Journal:  Biochim Biophys Acta       Date:  2014-07-23

Review 2.  Extra sensory perception: the role of Gpr receptors in the kidney.

Authors:  Jennifer L Pluznick
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-09       Impact factor: 2.894

Review 3.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

4.  A novel SCFA receptor, the microbiota, and blood pressure regulation.

Authors:  Jennifer Pluznick
Journal:  Gut Microbes       Date:  2013-12-20

5.  LGR4 and its ligands, R-spondin 1 and R-spondin 3, regulate food intake in the hypothalamus of male rats.

Authors:  Ji-Yao Li; Biaoxin Chai; Weizhen Zhang; Danielle M Fritze; Chao Zhang; Michael W Mulholland
Journal:  Endocrinology       Date:  2013-11-26       Impact factor: 4.736

6.  Ablation of LGR4 promotes energy expenditure by driving white-to-brown fat switch.

Authors:  Jiqiu Wang; Ruixin Liu; Feng Wang; Jie Hong; Xiaoying Li; Maopei Chen; Yingying Ke; Xianfeng Zhang; Qinyun Ma; Rui Wang; Juan Shi; Bin Cui; Weiqiong Gu; Yifei Zhang; Zhiguo Zhang; Weiqing Wang; Xuefeng Xia; Mingyao Liu; Guang Ning
Journal:  Nat Cell Biol       Date:  2013-11-10       Impact factor: 28.824

7.  Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression.

Authors:  Bing Du; Weijia Luo; Ruimei Li; Binghe Tan; Honghui Han; Xiaoling Lu; Dali Li; Min Qian; Dekai Zhang; Yongxiang Zhao; Mingyao Liu
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

8.  Lgr4 regulates mammary gland development and stem cell activity through the pluripotency transcription factor Sox2.

Authors:  Ying Wang; Jie Dong; Dali Li; Li Lai; Stefan Siwko; Yi Li; Mingyao Liu
Journal:  Stem Cells       Date:  2013-09       Impact factor: 6.277

9.  Lgr4 is a key regulator of prostate development and prostate stem cell differentiation.

Authors:  Weijia Luo; Melissa Rodriguez; Joseph M Valdez; Xinglei Zhu; Kunrong Tan; Dali Li; Stefan Siwko; Li Xin; Mingyao Liu
Journal:  Stem Cells       Date:  2013-11       Impact factor: 6.277

Review 10.  Renal and cardiovascular sensory receptors and blood pressure regulation.

Authors:  Jennifer L Pluznick
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.